Anova Joint Venture Company Limited
Anova Joint Venture Company Limited is a leading manufacturer and supplier of veterinary medicines and animal health products, headquartered in Thuận An, Vietnam. The company specializes in pharmaceutical solutions for livestock, poultry, aquaculture, and companion animals, providing high-quality, research-backed veterinary formulations to support animal health and productivity.
Core Business and Specialization
Anova is dedicated to developing, manufacturing, and distributing a wide range of veterinary medicines, feed additives, and biosecurity solutions. With a strong focus on disease prevention and treatment, the company ensures compliance with global safety standards and serves the needs of livestock, poultry, pet, and aquaculture industries.
Product Portfolio
Anova offers an extensive range of veterinary pharmaceuticals, categorized into:
1. Products for Cattle
- NOVA-COC 5% – Treatment for coccidiosis and intestinal infections.
- NOVA-COLISPEC – Antibiotic formulation for bacterial infections.
- NOVASONE – Anti-inflammatory and pain relief solution.
- NOVAZURIL – Antiparasitic treatment for internal and external parasites.
- NOVA-B.COMPLEX – Vitamin B-complex supplement for immune and metabolic support.
2. Products for Poultry
- NOVA-COC 5% – Supports gut health and coccidiosis control.
- NOVA-COLISPEC – Protects against bacterial infections in broilers and layers.
- NOVASONE – Anti-inflammatory medicine for respiratory diseases.
- NOVAZURIL – Antiparasitic solution for avian protozoal infections.
- NOVA-B.COMPLEX – Improves growth performance and egg production.
3. Products for Pets
- NOVA-COC 5% – Effective in controlling protozoal diseases in companion animals.
- NOVA-COLISPEC – Antibiotic therapy for skin and respiratory infections.
- NOVASONE – Pain relief and anti-inflammatory treatment.
- NOVAZURIL – Protection against parasites and intestinal infections.
- NOVA-B.COMPLEX – Nutritional supplement for pet wellness and energy metabolism.
4. Products for Shrimp
- NOVA-COC 5% – Supports intestinal health and disease resistance.
- NOVA-COLISPEC – Broad-spectrum antibacterial treatment.
- NOVASONE – Reduces stress-related inflammation.
- NOVAZURIL – Ensures better parasite control in shrimp farming.
- NOVA-B.COMPLEX – Boosts metabolism and immune function in aquatic species.
5. Products for Fish
- NOVA-COC 5% – Prevents protozoal infections in farmed fish.
- NOVA-COLISPEC – Antibacterial formula for aquaculture applications.
- NOVASONE – Reduces stress-induced immune suppression.
- NOVAZURIL – Treats parasitic infections in fish farms.
- NOVA-B.COMPLEX – Enhances growth performance and disease resistance.
Anova’s products are scientifically formulated to ensure optimal health, disease resistance, and performance enhancement across different animal species.
Market Position and Target Customers
Anova serves a diverse customer base, including:
- Livestock Producers & Dairy Farms – Ensuring disease control and nutritional balance.
- Poultry Farms & Integrators – Supporting high-performance poultry health management.
- Pet Care Industry – Offering companion animal health and wellness products.
- Aquaculture & Shrimp Farms – Enhancing disease prevention and feed conversion efficiency.
- Veterinarians & Distributors – Providing professional-grade pharmaceuticals for animal health care.
With a strong market presence in Vietnam and Southeast Asia, Anova continues to expand its footprint globally, supplying high-quality veterinary medicines and nutritional solutions.
Financial Strength and Industry Growth
The global veterinary medicine market is valued at over $40 billion, with a CAGR of 6-7%, driven by:
- Increasing demand for animal protein and sustainable livestock production.
- Rising prevalence of infectious diseases in animals.
- Growing pet ownership and spending on companion animal healthcare.
Anova is strategically positioned to capitalize on these industry trends, leveraging its research-driven product innovations and expanding global reach.
International Shipments and Export Presence
Anova has established export partnerships in Southeast Asia, Latin America, and the Middle East, supplying veterinary pharmaceuticals to major livestock and aquaculture markets. Trade data indicates steady export growth, reflecting the rising demand for high-quality animal health products.
Certifications and Regulatory Compliance
Anova ensures strict adherence to global regulatory frameworks, including:
- GMP (Good Manufacturing Practices) Certification – Ensuring high-quality pharmaceutical production.
- ISO 9001 Certification – Guaranteeing consistent quality control and safety.
- HACCP Compliance – Maintaining feed and food safety standards.
- Vietnam Ministry of Agriculture & Rural Development (MARD) Approval – Meeting national veterinary pharmaceutical standards.
- International Veterinary Drug Regulations Compliance – Enabling global market access.
These certifications position Anova as a leading, trusted supplier of veterinary medicines and animal health solutions.
Competitive Advantages and Unique Selling Proposition
- Advanced Veterinary Pharmaceutical Research – Developing scientifically validated, high-efficacy formulations.
- Comprehensive Product Portfolio – Offering solutions for livestock, poultry, pets, and aquaculture.
- Strong Regional and Global Market Presence – Serving Vietnam, Southeast Asia, and international markets.
- Commitment to Quality and Compliance – Meeting global veterinary pharmaceutical standards.
- Sustainability-Focused Solutions – Promoting antibiotic alternatives and disease prevention strategies.
Major Achievements
- Expanded veterinary pharmaceutical distribution to multiple international markets.
- Strengthened R&D capabilities, leading to the development of innovative drug formulations.
- Achieved ISO, GMP, and HACCP certification, ensuring high-quality production and safety.
- Partnered with veterinary experts and research institutions to advance animal healthcare.
- Maintained leadership in Vietnam’s animal health industry, supplying top-tier veterinary solutions to commercial farms.
Anova Joint Venture Company Limited continues to lead the animal health industry, delivering scientifically proven, performance-driven veterinary medicines and feed additives that support sustainable and profitable animal production worldwide.
